Optimizing Ki-67 and E-Cadherin Thresholds for Improved Grade and Stage Classification in Urothelial Bladder Cancer
Journal of Clinical Medicine · 02.01.2026 · 15 (1) · 338
DOI: 10.3390/jcm15010338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.01.2026. Verfasst von Stefan Harsanyi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Operational Program Integrated Infrastructure.
Abstract (Originalsprache)
Background
Bladder cancer exhibits substantial heterogeneity, and accurate discrimination between non-muscle-invasive (NMIBC) and muscle-invasive disease (MIBC), as well as between low-grade (LG) and high-grade (HG) tumors, remains essential for appropriate clinical management. Established immunohistochemical (IHC) markers, such as p53, Ki-67, and E-cadherin, could be used in a new setting, but standardized cut-off values and their combined predictive value remain unclear. This study aimed to identify optimal cut-offs for these markers and to evaluate whether biomarker combinations enhance the discrimination of tumor grade and stage.
Methods
A retrospective dataset of 568 cases of bladder cancer was analyzed. For each case, the expression of p53, Ki-67, and E-cadherin was quantified, and tumors were classified as NMIBC or MIBC, and as LG or HG. ROC-based cut-off selection was performed using Youden’s J criterion with 10-fold stratified cross-validation. E-cadherin was modelled using an inverted scale to reflect biological loss. Logistic regression models were used to evaluate the discriminatory performance of single markers, two-marker combinations, and a three-marker model. Cross-validated AUC values and optimal thresholds were reported.
Results
Ki-67 showed the strongest single-marker performance for predicting both MIBC (AUC 0.842) and HG disease (AUC 0.813), with optimal cut-offs of ≥40% and ≥30%, respectively. p53 demonstrated moderate discrimination (AUC 0.778 for MIBC and 0.776 for HG), while E-cadherin, evaluated on an inverted scale, showed acceptable performance (AUC 0.746 for MIBC; 0.780 for HG). Combining markers yielded modest improvements, with the best performance observed for Ki-67 + E-cadherin (AUCs of 0.851 for MIBC and 0.838 for HG).
Conclusions
Ki-67 is the most effective single biomarker for distinguishing invasive and HG bladder cancer, while E-cadherin provides complementary value. A two-marker panel combining Ki-67 and E-cadherin, using appropriate cut-offs, offers the highest overall performance and may serve as a practical tool for enhanced pathological stratification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.
- Institute of Forensic Medicine, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.
- Department of Urology, Faculty of Medicine, Comenius University in Bratislava, 826 06 Bratislava, Slovakia.
- Institute of Anatomy, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.
ORCID-Profile: Stefan Harsanyi, Lubos Danisovic
Förderung
- Operational Program Integrated Infrastructure
Zitieren
APA
Harsanyi, S., Novakova, Z. V., Neuschlova, L., Galbavy, S., Danisovic, L., Ziaran, S., & Bevizova, K. (2026). Optimizing Ki-67 and E-Cadherin Thresholds for Improved Grade and Stage Classification in Urothelial Bladder Cancer. Journal of Clinical Medicine, 15(1), 338. https://doi.org/10.3390/jcm15010338
Vancouver
Harsanyi S, Novakova ZV, Neuschlova L, Galbavy S, Danisovic L, Ziaran S, et al. Optimizing Ki-67 and E-Cadherin Thresholds for Improved Grade and Stage Classification in Urothelial Bladder Cancer. Journal of Clinical Medicine. 2026;15(1):338. doi:10.3390/jcm15010338
BibTeX
@article{Harsanyi2026,
author = {Harsanyi, Stefan and Novakova, Zuzana Varchulova and Neuschlova, Lucia and Galbavy, Stefan and Danisovic, Lubos and Ziaran, Stanislav and Bevizova, Katarina},
title = {Optimizing Ki-67 and E-Cadherin Thresholds for Improved Grade and Stage Classification in Urothelial Bladder Cancer},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {1},
pages = {338},
doi = {10.3390/jcm15010338}
}
EUVIMED